Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024
2024年3月6日 - 2:00AM
RNSを含む英国規制内ニュース (英語)
Monthly information related to total number of voting rights and
shares composing the share capital - February 29, 2024
Monthly information related to total
number of voting rights and shares composing the share capital -
February 29, 2024
Article 223-16 of general regulation
of French Autorité des Marchés Financiers
Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code:
FR001400K4B1- Symbol: PHXM) &
Nasdaq Global Select Market in the United-States (Symbol: PHXM)
Website : www.phaxiam.com
Date |
Total of shares composing the share capital |
Total of brut (1)
voting rights |
Total of net
(2)
voting rights
|
December 31, 2023 |
6 075 105 |
6 226 982 |
6 226 733 |
January 31, 2024 |
6 075 105 |
6 227 002 |
6 226 753 |
February 29, 2024 |
6 075 105 |
6 226 951 |
6 226 702 |
(1) Gross voting
rights number (or « theoretical » voting rights) is used
as a basis for calculating the crossing of the threshold. In
accordance with article 223-11 of general regulation of
Autorité des Marchés Financiers,
this number is calculated on the basis of
all shares carrying the single and double voting rights,
including shares without voting rights.
(2) Without treasury
shares.
- CP_Déclaration Droits de Vote 29 02 2024_vENG
Phaxiam Therapeutics (LSE:0QSS)
過去 株価チャート
から 5 2024 まで 6 2024
Phaxiam Therapeutics (LSE:0QSS)
過去 株価チャート
から 6 2023 まで 6 2024